Collaborating to improve health

Janssen Europe, Middle East and Africa report

banner

banner

 

banner

Welcome to the Janssen EMEA report “Collaborating To Improve Health”. 

 

Stakeholder perspectives

Vivienne Parry
Journalist UK
Public trust in pharma is at an all-time low.

Stakeholder perspectives

Bernat Soria
Director of CABIMER, Former Minister of Health, Spain
Health is not the result of a single action.

Stakeholder perspectives

Terry Hammond
Caregiver and father of Steve, a schizophrenia patient
The future has to be about partnership working.

Stakeholder perspectives

Dr. James Kingsland
President, National Association of Primary Care, UK and local commissioner
We also need to be transparent in common goals.

Stakeholder perspectives

Helga Rohra
Early stage dementia patient & dementia advocate
Include dementia patients in your programmes and ask their opinions.

Stakeholder perspectives

Eric Low
Chief Executive, Myeloma UK
It’s incumbent on industry and academics to work together.

Stakeholder perspectives

Françoise Meunier
Director General, European Organisation of Research and Treatment of Cancer
The current healthcare challenges are forcing everyone to work together.

Stakeholder perspectives

Michael Barry
Director, National Centre for Pharmacoeconomics, Ireland
It’s about communication, openness and transparency.

Stakeholder perspectives

Mary Harney
Former Government Minister, Ireland
Director of several companies
The first moves must come from the pharmaceutical companies.

Stakeholder perspectives

Ivan Gardini
Founder & President, Epac Onlus
Patients Organisation (Hepatitis C)
The pharma industry has to be more transparent.

Stakeholder perspectives

Mélanie Aubin
Psoriasis patient
Head of communications
National French Association of Psoriasis
Do not forget the patient – this is the goal.

Stakeholder perspectives

Kyle Jacques Rose
Founder & Managing Director,
Delta PM Diabetes Patient Advocacy
Include patient representatives from across the chronic diseases.

Stakeholder perspectives

Panos Kanavos
Reader in Health Policy
London School of Economics Health
United Kingdom
Understanding the needs of healthcare systems requires some upscaling of skills in the pharma industry.

Stakeholder perspectives

Dr. Rafael Bengoa
Health Department Director
DEUSTO Business School, Spain
Emerging new healthcare models are providing the industry and healthcare professionals a common agenda to work in partnership.

Stakeholder perspectives

Dr. Mustafa Al Maini
Deputy Medical Director
Chief of Rheumatology, Allergy & Clinical Immunology
Mafraq Hospital, United Arab Emirates
Pharma needs to understand my needs – which are the patients’ needs.

Janssen Europe, the Middle-East and Africa (EMEA) in a nutshell

  • Pharmaceutical company of Johnson & Johnson
  • More than 14,000 employees
  • Local offices in more than 30 countries
  • 8 R&D Centres in EMEA
  • 8 Manufacturing sites
  • Activities in more than 100 countries

Clinical Trial Data Transparency

 

Janssen to the rescue of ancient warriors

 

A new generation of expert patients

 

Partnering to save children’s lives